grafts, but the insulin concentration, as expressed per \ g=m\ g DNA, was decreased by 40% in the streptozotocin-treated islets. The insulin release of the grafts, during perfusion of the graft-bearing kidney in situ with 16.7 mmol/l glucose was diminished in the streptozotocin group, whilst perfusion with 16.7 mmol/l glucose plus 5 mmol/l theophylline was able partially to counteract the reduction in insulin release. In the second set of experiments, NMRI mice were injected iv with 160 mg/kg streptozotocin or vehicle alone, and their islets isolated 15 min after the injections. After 6 days in culture, there was no decrease in DNA, glucagon and somatostatin contents, but the insulin content was decreased by 40% in the streptozotocin exposed islets. These islets also showed a 60% decrease in the insulin response to glucose, which was partly counteracted by incubation with 16 .7 mmol/1 glucose plus 5 mmol/l theophylline. These observations suggest that a defective response to glucose, in conjunction with a better response to non-nutrient secretagogues, may be a common property of pancreatic islets following toxin\x=req-\ induced disturbances.
Type I, or insulin-dependent diabetes mellitus (IDDM), is characterized by a severe insulin defi¬ ciency, secondary to impaired B-cell function and B-cell destruction. Despite the abrupt onset of symptoms, the autoimmune process leading to IDDM appears to evolve slowly over several years (1) . A remarkable clinical feature in this 'prediabetic' period is a progressively developing in¬ ability to secrete insulin in response to intravenous glucose, while still maintaining a partial response to other secretagogues such as arginine and glucagon (2) . Similar findings have been described in animal models of spontaneous (3, 4) or drug-in¬ duced diabetes (5) . The reasons lor this selective loss of response to glucose are unknown, but it has been suggested to reflect a deleterious effect of an excessive glucose stimulation on a reduced B-cell mass (5) . Another (12) . Furthermore, at that concen¬ tration it is still possible to recover most of the SZ-exposed islets (8, 12 (16, 17) .
Experiments with islets exposed to streptozotocin in vivo followed by islet isolation and subsequent culture for 6 days Non-fasted male NMRI mice were injected with SZ or 0.2 ml vehicle (CB) only. SZ was dissolved immediately before use in CB and administered iv at a diabetogenic dose of 160 mg/kg body weight (18) . After (Fig. 1) Experiments with islets exposed to streptozotocin in vivo followed by islet isolation and subsequent culture for 6 (Table 4) , did not alter the above described observations. (18) . Thus, when the mice were killed 14 days after the SZ injection, there was a marked decrease in the number of is¬ lets, and the few remaining islets showed a severely altered architechture and pyknotic cell nuclei (18) . Quite in contrast, a great majority of islets isolated 15 min after the SZ injection and subsequently kept in culture survived (Table 3) and, though functionally impaired in a way similar to that of is¬ lets exposed to SZ in vitro (8) 
